Connected Drug Injection Devices

  • ID: 3617214
  • Report
  • Region: Global
  • Greystone Associates
1 of 3
For self-administration, adherence with drug therapy and disease management protocols has become a primary concern within the healthcare and pharmaceutical industries. For chronic conditions adherence has a direct effect on the patient’s quality-of-life. Connected devices - drug injection devices that are designed to address the patient adherence issue by reminding and recording data about patient dosing activity and making it available to HCPs - are gaining interest among industry and managed care participants.

Efforts to enhance adherence have a non-negligible effect on drug formulations and delivery decisions, and are a significant factor in the prescribing decisions of most physicians. The connected device ecosystem includes OEM device suppliers, drug developers, human factors consultants and aftermarket third-party devices.

What You Will Learn

- What drug injection devices incorporate wireless connectivity technology, how do they work and what new capabilities do they offer to patients and their HCPs?

- What benefits do connected drug injectors provide to patients in the area of improved adherence? Patient reported outcomes? HCP/patient communication?

- What therapeutic areas are the current focus of connected devices?

- Who are the companies behind the push to connected injection devices? What are their development activities and corporate alliances and affiliations

- What is the importance of pharma-device alliances and design partnerships on connected drug injection device commercialization and market access?

- What does the current market for connected drug injection devices look like? What will it look like in 2020?

- What are the key market drivers for the growth of connected injection devices?

Who Should Read This Report


- Drug Developers
- Device Suppliers
- CMOs
- Components/APIs
- Testing/Validation
- Clinical Trial Mgmt


- Pharma Managers
- Biotech Managers
- Drug Marketers
- Industry Strategists
- Financial Analysts
- Management
- Consultants


- Clinical Managers
- Drug Distributors
- Pharma Regulators
- FDA Consultants
- Managed Care Managers
Note: Product cover images may vary from those shown
2 of 3
1. Executive Summary

2. Connected Devices – The Opportunity
- Injectable Drug Development Trends
- The Rapid Rise of Prefilled Injection Devices
- Factors Driving Drug Self-Administration
- Therapeutic Demand Drivers
- The Impact of Developing Economies

3. Connectivity Technologies
- Wireless Technologies
- Bluetooth
- Cellular
- Near Field Communications
- Wired Technologies

4. Connected Devices
- Wearable Devices
- Connected Autoinjectors
- Non-drug Specific Connected Injectors
- Automated Connected Injectors
- Vendor-specific Connectivity Platforms
- Third Party Connectivity Devices

5. Near-term Markets for Connected Injection Devices
- Anaphylaxis
- Autoimmune Disease
- Cardiovascular
- Diabetes
- Hormone Replacement

6. Market Factors
- Regulatory Requirements
- Data Security
- Patient Acceptance

7. Company Profiles
Note: Product cover images may vary from those shown
3 of 3


4 of 3
Note: Product cover images may vary from those shown